Among different forms of TMA, thrombotic thrombocytopenic purpura (TTP) is characterized by deficient ADAMTS-13 activity, with atypical hemolytic uremic syndrome (aHUS) by the dysregulation of the complement system’s alternative pathway [16]. The gene discussed is ADAMTS13; the disease is atypical hemolytic-uremic syndrome.